Mast cell mediators: Their differential release and the secretory pathways involved

Frontiers in Immunology

Volumn 5, Issue NOV, 2014, Pages

  Moon, Tae Chul ^a   Dean Befus, A ^a   Kulka, Marianna ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

Exocytosis; Exosome; Granule; Lipid body; Lysosome; Secretion

Indexed keywords

ARYLSULFATASE; BETA GLUCURONIDASE; BETA N ACETYLHEXOSAMINIDASE; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; CARBOXYPEPTIDASE A; CASPASE 3; CATHEPSIN G; CHONDROITIN SULFATE; CHYMASE; FIBROBLAST GROWTH FACTOR 2; G PROTEIN COUPLED RECEPTOR; GRANZYME B; HEPARIN; HISTAMINE; IMMUNOGLOBULIN E; INTERLEUKIN 1BETA; INTERLEUKIN 4; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2; PEPTIDOLEUKOTRIENE; PROTEOGLYCAN; RAB PROTEIN; REACTIVE OXYGEN METABOLITE; SEROTONIN; SOMATOMEDIN B RECEPTOR; SYNAPTOTAGMIN; TOLL LIKE RECEPTOR; TRYPTASE; TUMOR NECROSIS FACTOR; UNINDEXED DRUG;

ADAPTIVE IMMUNITY; APOPTOSIS; BIOGENESIS; CELL ACTIVATION; CELL HETEROGENEITY; CELL MATURATION; CELL MIGRATION; EXOCYTOSIS; EXOSOME; FIBROSIS; HOST RESISTANCE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREGULATION; INNATE IMMUNITY; MAST CELL; MAST CELL DEGRANULATION; MORPHOLOGY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN SYNTHESIS; PROTEIN TARGETING; REVIEW; SECRETORY PATHWAY;

EID: 84919390414     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00569     Document Type: Review

References (210)

1. Moon TC, St Laurent CD, Morris KE, Marcet C, Yoshimura T, Sekar Y, et al. Advances in mast cell biology: new understanding of heterogeneity and function. Mucosal Immunol (2010) 3(2):111-28. doi: 10.1038/mi.2009.136
2. Lancaster JR Jr. A tutorial on the diffusibility and reactivity of free nitric oxide. Nitric Oxide (1997) 1(1):18-30. doi:10.1006/niox.1996.0112
3. Lacy P, Stow JL. Cytokine release from innate immune cells: association with diverse membrane trafficking pathways. Blood (2011) 118(1):9-18. doi:10.1182/blood-2010-08-265892
4. Mori S, Saino T, Satoh Y. Effect of low temperatures on compound 48/80-induced intracellular Ca2+ changes and exocytosis of rat peritoneal mast cells. Arch Histol Cytol (2000) 63(3):261-70. doi:10.1679/aohc.63.261
5. Schick B, Austen KF. Rat serosal mast cell degranulation mediated by chymase, an endogenous secretory granule protease: active site-dependent initiation at 1 degree C. J Immunol (1986) 136(10):3812-8.
6. Alfonso A, Cabado AG, Vieytes MR, Botana LM. Calcium-pH crosstalks in rat mast cells: cytosolic alkalinization, but not intracellular calcium release, is a sufficient signal for degranulation. Br J Pharmacol (2000) 130(8):1809-16. doi:10.1038/sj.bjp.0703490
7. Muller K, Meineke V. Radiation-induced mast cell mediators differentially modulate chemokine release from dermal fibroblasts. J Dermatol Sci (2011) 61(3):199-205. doi:10.1016/j.jdermsci.2011.01.003
8. Gulliksson M, Palmberg L, Nilsson G, Ahlstedt S, Kumlin M. Release of prostaglandin D2 and leukotriene C4 in response to hyperosmolar stimulation of mast cells. Allergy (2006) 61(12):1473-9. doi:10.1111/j.1398-9995.2006.01213.x
9. Wernersson S, Pejler G. Mast cell secretory granules: armed for battle. Nat Rev Immunol (2014) 14(7):478-94. doi:10.1038/nri3690
10. Chicoine E, Esteve PO, Robledo O, Van Themsche C, Potworowski EF, St-Pierre Y. Evidence for the role of promoter methylation in the regulation of MMP-9 gene expression. Biochem Biophys Res Commun (2002) 297(4):765-72. doi:10.1016/S0006-291X(02)02283-0
11. Burgoyne RD, Morgan A. Secretory granule exocytosis. Physiol Rev (2003) 83(2):581-632. doi:10.1152/physrev.00031.2002
12. Karp G. Cell Biology. 6th ed. Hoboken: John Wiley & Sons Inc (2010).
13. Silver RB, Pappas GD. Secretion without membrane fusion: porocytosis. Anat Rec B New Anat (2005) 282(1):18-37. doi:10.1002/ar.b.20050
14. Lorentz A, Baumann A, Vitte J, Blank U. The SNARE machinery in mast cell secretion. Front Immunol (2012) 3:143. doi:10.3389/fimmu.2012.00143
15. Hammel I, Lagunoff D, Galli SJ. Regulation of secretory granule size by the precise generation and fusion of unit granules. J Cell Mol Med (2010) 14(7):1904-16. doi:10.1111/j.1582-4934.2010.01071.x
16. Carroll-Portillo A, Surviladze Z, Cambi A, Lidke DS, Wilson BS. Mast cell synapses and exosomes: membrane contacts for information exchange. Front Immunol (2012) 3:46. doi:10.3389/fimmu.2012.00046
17. Galli SJ, Tsai M. IgE and mast cells in allergic disease. Nat Med (2012) 18(5):693-704. doi:10.1038/nm.2755
18. Benado A, Nasagi-Atiya Y, Sagi-Eisenberg R. Protein trafficking in immune cells. Immunobiology (2009) 214(6):403-21. doi:10.1016/j.imbio.2008.11.011
19. Stow JL, Murray RZ. Intracellular trafficking and secretion of inflammatory cytokines. Cytokine Growth Factor Rev (2013) 24(3):227-39. doi:10.1016/j.cytogfr.2013.04.001
20. Schwartz LB, Lewis RA, Seldin D, Austen KF. Acid hydrolases and tryptase from secretory granules of dispersed human lung mast cells. J Immunol (1981) 126(4):1290-4.
21. Miller JS, Westin EH, Schwartz LB. Cloning and characterization of complementary DNA for human tryptase. J Clin Invest (1989) 84(4):1188-95. doi:10.1172/JCI114284
22. Miller JS, Moxley G, Schwartz LB. Cloning and characterization of a second complementary DNA for human tryptase. J Clin Invest (1990) 86(3):864-70. doi:10.1172/JCI114786
23. Vanderslice P, Ballinger SM, Tam EK, Goldstein SM, Craik CS, Caughey GH. Human mast cell tryptase: multiple cDNAs and genes reveal a multigene serine protease family. Proc Natl Acad Sci U S A (1990) 87(10):3811-5. doi:10.1073/pnas.87.10.3811
24. Wong GW, Tang Y, Feyfant E, Sali A, Li L, Li Y, et al. Identification of a new member of the tryptase family of mouse and human mast cell proteases which possesses a novel COOH-terminal hydrophobic extension. J Biol Chem (1999) 274(43):30784-93. doi:10.1074/jbc.274.43.30784
25. Caughey GH, Raymond WW, Blount JL, Hau LW, Pallaoro M, Wolters PJ, et al. Characterization of human gamma-tryptases, novel members of the chromosome 16p mast cell tryptase and prostasin gene families. J Immunol (2000) 164(12):6566-75. doi:10.4049/jimmunol.164.12.6566
26. Wang HW, McNeil HP, Husain A, Liu K, Tedla N, Thomas PS, et al. Delta tryptase is expressed in multiple human tissues, and a recombinant form has proteolytic activity. J Immunol (2002) 169(9):5145-52. doi:10.4049/jimmunol.169.9.5145
27. Wong GW, Foster PS, Yasuda S, Qi JC, Mahalingam S, Mellor EA, et al. Biochemical and functional characterization of human transmembrane tryptase (TMT)/tryptase gamma. TMT is an exocytosed mast cell protease that induces airway hyperresponsiveness in vivo via an interleukin-13/interleukin-4 receptor alpha/signal transducer and activator of transcription (STAT) 6-dependent pathway. J Biol Chem (2002) 277(44):41906-15. doi:10.1074/jbc.M205868200
28. Schwartz LB, Irani AM, Roller K, Castells MC, Schechter NM. Quantitation of histamine, tryptase, and chymase in dispersed human T and TC mast cells. J Immunol (1987) 138(8):2611-5.
29. Pejler G, Knight SD, Henningsson F, Wernersson S. Novel insights into the biological function of mast cell carboxypeptidase A. Trends Immunol (2009) 30(8):401-8. doi:10.1016/j.it.2009.04.008
30. Schechter NM, Wang ZM, Blacher RW, Lessin SR, Lazarus GS, Rubin H. Determination of the primary structures of human skin chymase and cathepsin G from cutaneous mast cells of urticaria pigmentosa lesions. J Immunol (1994) 152(8):4062-9.
31. Strik MC, de Koning PJ, Kleijmeer MJ, Bladergroen BA, Wolbink AM, Griffith JM, et al. Human mast cells produce and release the cytotoxic lymphocyte associated protease granzyme B upon activation. Mol Immunol (2007) 44(14):3462-72. doi:10.1016/j.molimm.2007.03.024
32. Olszewski MB, Groot AJ, Dastych J, Knol EF. TNF trafficking to human mast cell granules: mature chain-dependent endocytosis. J Immunol (2007) 178(9):5701-9. doi:10.4049/jimmunol.178.9.5701
33. Dvorak AM, Morgan ES, Weller PF. Ultrastructural immunolocalization of basic fibroblast growth factor to lipid bodies and secretory granules in human mast cells. Histochem J (2001) 33(7):397-402. doi:10.1023/A:1013771827069
34. Wilson SJ, Shute JK, Holgate ST, Howarth PH, Bradding P. Localization of interleukin (IL) -4 but not IL-5 to human mast cell secretory granules by immunoelectron microscopy. Clin Exp Allergy (2000) 30(4):493-500. doi:10.1046/j.1365-2222.2000.00756.x
35. de Paulis A, Minopoli G, Arbustini E, de Crescenzo G, Dal Piaz F, Pucci P, et al. Stem cell factor is localized in, released from, and cleaved by human mast cells. J Immunol (1999) 163(5):2799-808.
36. Stevens RL, Fox CC, Lichtenstein LM, Austen KF. Identification of chondroitin sulfate E proteoglycans and heparin proteoglycans in the secretory granules of human lung mast cells. Proc Natl Acad Sci U S A (1988) 85(7):2284-7. doi:10.1073/pnas.85.7.2284
37. Metcalfe DD, Lewis RA, Silbert JE, Rosenberg RD, Wasserman SI, Austen KF. Isolation and characterization of heparin from human lung. J Clin Invest (1979) 64(6):1537-43. doi:10.1172/JCI109613
38. Uvnas B. Recent observations on mechanisms of storage and release of mast cell histamine. Applicability to other biogenic amines. Agents Actions Suppl (1992) 36:23-33.
39. Hogan AD, Schwartz LB. Markers of mast cell degranulation. Methods (1997) 13(1):43-52. doi:10.1006/meth.1997.0494
40. Hohman RJ, Dreskin SC. Measuring degranulation of mast cells. Curr Protoc Immunol (2001) Chapter 7:Unit726. doi:10.1002/0471142735.im0726s08
41. Douaiher J, Succar J, Lancerotto L, Gurish MF, Orgill DP, Hamilton MJ, et al. Development of mast cells and importance of their tryptase and chymase serine proteases in inflammation and wound healing. Adv Immunol (2014) 122:211-52. doi:10.1016/B978-0-12-800267-4.00006-7
42. Baram D, Adachi R, Medalia O, Tuvim M, Dickey BF, Mekori YA, et al. Synaptotagmin II negatively regulates Ca2+-triggered exocytosis of lysosomes in mast cells. J Exp Med (1999) 189(10):1649-58. doi:10.1084/jem.189.10.1649
43. Raposo G, Tenza D, Mecheri S, Peronet R, Bonnerot C, Desaymard C. Accumulation of major histocompatibility complex class II molecules in mast cell secretory granules and their release upon degranulation. Mol Biol Cell (1997) 8(12):2631-45. doi:10.1091/mbc.8.12.2631
44. Puri N, Roche PA. Mast cells possess distinct secretory granule subsets whose exocytosis is regulated by different SNARE isoforms. Proc Natl Acad Sci U S A (2008) 105(7):2580-5. doi:10.1073/pnas.0707854105
45. Gunin AG, Kornilova NK, Vasilieva OV, Petrov VV. Age-related changes in proliferation, the numbers of mast cells, eosinophils, and CD45-positive cells in human dermis. J Gerontol A Biol Sci Med Sci (2011) 66(4):385-92. doi:10.1093/gerona/glq205
46. Hammel I, Dvorak AM, Peters SP, Schulman ES, Dvorak HF, Lichtenstein LM, et al. Differences in the volume distributions of human lung mast cell granules and lipid bodies: evidence that the size of these organelles is regulated by distinct mechanisms. J Cell Biol (1985) 100(5):1488-92. doi:10.1083/jcb.100.5.1488
47. Riedel D, Antonin W, Fernandez-Chacon R, Alvarez de Toledo G, Jo T, Geppert M, et al. Rab3D is not required for exocrine exocytosis but for maintenance of normally sized secretory granules. Mol Cell Biol (2002) 22(18):6487-97. doi:10.1128/MCB.22.18.6487-6497.2002
48. Azouz NP, Zur N, Efergan A, Ohbayashi N, Fukuda M, Amihai D, et al. Rab5 is a novel regulator of mast cell secretory granules: impact on size, cargo, and exocytosis. J Immunol (2014) 192(9):4043-53. doi:10.4049/jimmunol.1302196
49. Durchfort N, Verhoef S, Vaughn MB, Shrestha R, Adam D, Kaplan J, et al. The enlarged lysosomes in beige j cells result from decreased lysosome fission and not increased lysosome fusion. Traffic (2012) 13(1):108-19. doi:10.1111/j.1600-0854.2011.01300.x
50. Grimberg E, Peng Z, Hammel I, Sagi-Eisenberg R. Synaptotagmin III is a critical factor for the formation of the perinuclear endocytic recycling compartment and determination of secretory granules size. J Cell Sci (2003) 116(Pt 1):145-54. doi:10.1242/jcs.00186
51. Prasad P, Yanagihara AA, Small-Howard AL, Turner H, Stokes AJ. Secretogranin III directs secretory vesicle biogenesis in mast cells in a manner dependent upon interaction with chromogranin A. J Immunol (2008) 181(7):5024-34. doi:10.4049/jimmunol.181.7.5024
52. Henningsson F, Hergeth S, Cortelius R, Abrink M, Pejler G. A role for serglycin proteoglycan in granular retention and processing of mast cell secretory granule components. FEBS J (2006) 273(21):4901-12. doi:10.1111/j.1742-4658.2006.05489.x
53. Melo FR, Waern I, Ronnberg E, Abrink M, Lee DM, Schlenner SM, et al. A role for serglycin proteoglycan in mast cell apoptosis induced by a secretory granule-mediated pathway. J Biol Chem (2011) 286(7):5423-33. doi:10.1074/jbc.M110.176461
54. Nakazawa S, Sakanaka M, Furuta K, Natsuhara M, Takano H, Tsuchiya S, et al. Histamine synthesis is required for granule maturation in murine mast cells. Eur J Immunol (2014) 44(1):204-14. doi:10.1002/eji.201343838
55. Doray B, Kornfeld S. Gamma subunit of the AP-1 adaptor complex binds clathrin: implications for cooperative binding in coated vesicle assembly. Mol Biol Cell (2001) 12(7):1925-35. doi:10.1091/mbc.12.7.1925
56. Bonnemaison ML, Eipper BA, Mains RE. Role of adaptor proteins in secretory granule biogenesis and maturation. Front Endocrinol (2013) 4:101. doi:10.3389/fendo.2013.00101
57. Lagunoff D. Analysis of dye binding sites in mast cell granules. Biochemistry (1974) 13(19):3982-6. doi:10.1021/bi00716a025
58. Nitzany E, Hammel I, Meilijson I. Quantal basis of vesicle growth and information content, a unified approach. J Theor Biol (2010) 266(1):202-9. doi:10.1016/j.jtbi.2010.06.019
59. Chin WC, Orellana MV, Quesada I, Verdugo P. Secretion in unicellular marine phytoplankton: demonstration of regulated exocytosis in Phaeocystis globosa. Plant Cell Physiol (2004) 45(5):535-42. doi:10.1093/pcp/pch062
60. Ronnberg E, Melo FR, Pejler G. Mast cell proteoglycans. J Histochem Cytochem (2012) 60(12):950-62. doi:10.1369/0022155412458927
61. Ikeya M, Yamanoue K, Mochizuki Y, Konishi H, Tadokoro S, Tanaka M, et al. Orai-2 is localized on secretory granules and regulates antigen-evoked Ca2+ mobilization and exocytosis in mast cells. Biochem Biophys Res Commun (2014) 451(1):62-7. doi:10.1016/j.bbrc.2014.07.060
62. Melicoff E, Sansores-Garcia L, Gomez A, Moreira DC, Datta P, Thakur P, et al. Synaptotagmin-2 controls regulated exocytosis but not other secretory responses of mast cells. J Biol Chem (2009) 284(29):19445-51. doi:10.1074/jbc.M109.002550
63. Biederbick A, Licht A, Kleene R. Serglycin proteoglycan is sorted into zymogen granules of rat pancreatic acinar cells. Eur J Cell Biol (2003) 82(1):19-29. doi:10.1078/0171-9335-00287
64. Merickel A, Edwards RH. Transport of histamine by vesicular monoamine transporter-2. Neuropharmacology (1995) 34(11):1543-7. doi:10.1016/0028-3908(95)00148-Y
65. Travis ER, Wang YM, Michael DJ, Caron MG, Wightman RM. Differential quantal release of histamine and 5-hydroxytryptamine from mast cells of vesicular monoamine transporter 2 knockout mice. Proc Natl Acad Sci U S A (2000) 97(1):162-7. doi:10.1073/pnas.97.1.162
66. Ringvall M, Ronnberg E, Wernersson S, Duelli A, Henningsson F, Abrink M, et al. Serotonin and histamine storage in mast cell secretory granules is dependent on serglycin proteoglycan. J Allergy Clin Immunol (2008) 121(4):1020-6. doi:10.1016/j.jaci.2007.11.031
67. Humphries DE, Wong GW, Friend DS, Gurish MF, Qiu WT, Huang C, et al. Heparin is essential for the storage of specific granule proteases in mast cells. Nature (1999) 400(6746):769-72. doi:10.1038/23481
68. Uvnas B, Aborg CH, Bergendorff A. Storage of histamine in mast cells. Evidence for an ionic binding of histamine to protein carboxyls in the granule heparin-protein complex. Acta Physiol Scand Suppl (1970) 336:1-26.
69. Rabenstein DL, Bratt P, Peng J. Quantitative characterization of the binding of histamine by heparin. Biochemistry (1998) 37(40):14121-7. doi:10.1021/bi980625y
70. Bergendorff A, Uvnas B. Storage of 5-hydroxytryptamine in rat mast cells. Evidence for an ionic binding to carboxyl groups in a granule heparin-protein complex. Acta Physiol Scand (1972) 84(3):320-31. doi:10.1111/j.1748-1716.1972.tb05183.x
71. Garcia-Faroldi G, Rodriguez CE, Urdiales JL, Perez-Pomares JM, Davila JC, Pejler G, et al. Polyamines are present in mast cell secretory granules and are important for granule homeostasis. PLoS One (2010) 5(11):11. doi:10.1371/journal.pone.0015071
72. Olszewski MB, Trzaska D, Knol EF, Adamczewska V, Dastych J. Efficient sorting of TNF-alpha to rodent mast cell granules is dependent on N-linked glycosylation. Eur J Immunol (2006) 36(4):997-1008. doi:10.1002/eji.200535323
73. Benyon RC, Bissonnette EY, Befus AD. Tumor necrosis factor-alpha dependent cytotoxicity of human skin mast cells is enhanced by anti-IgE antibodies. J Immunol (1991) 147(7):2253-8.
74. Gordon JR, Galli SJ. Mast cells as a source of both preformed and immunologically inducible TNF-alpha/cachectin. Nature (1990) 346(6281):274-6. doi:10.1038/346274a0
75. Okayama Y, Kobayashi H, Ashman LK, Dobashi K, Nakazawa T, Holgate ST, et al. Human lung mast cells are enriched in the capacity to produce granulocyte-macrophage colony-stimulating factor in response to IgE-dependent stimulation. Eur J Immunol (1998) 28(2):708-15. doi:10.1002/(SICI)1521-4141(199802)28:02<708::AID-IMMU708>3.0.CO;2-A
76. Voehringer D. Protective and pathological roles of mast cells and basophils. Nat Rev Immunol (2013) 13(5):362-75. doi:10.1038/nri3427
77. Moscatelli D. High and low affinity binding sites for basic fibroblast growth factor on cultured cells: absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells. J Cell Physiol (1987) 131(1):123-30. doi:10.1002/jcp.1041310118
78. Dvorak AM, McLeod RS, Onderdonk A, Monahan-Earley RA, Cullen JB, Antonioli DA, et al. Ultrastructural evidence for piecemeal and anaphylactic degranulation of human gut mucosal mast cells in vivo. Int Arch Allergy Immunol (1992) 99(1):74-83. doi:10.1159/000236338
79. Dvorak AM, Morgan ES. Diamine oxidase-gold enzyme-affinity ultrastructural demonstration that human gut mucosal mast cells secrete histamine by piecemeal degranulation in vivo. J Allergy Clin Immunol (1997) 99(6 Pt 1):812-20. doi:10.1016/S0091-6749(97)80016-4
80. Ebihara N, Watanabe Y, Murakami A. The ultramicrostructure of secretory granules of mast cells in giant papillae of vernal keratoconjunctivitis patients. Nihon Ganka Gakkai Zasshi (2008) 112(7):581-9.
81. Dvorak AM, Massey W, Warner J, Kissell S, Kagey-Sobotka A, Lichtenstein LM. IgE-mediated anaphylactic degranulation of isolated human skin mast cells. Blood (1991) 77(3):569-78.
82. Dvorak AM, Kissell S. Granule changes of human skin mast cells characteristic of piecemeal degranulation and associated with recovery during wound healing in situ. J Leukoc Biol (1991) 49(2):197-210.
83. Dvorak AM, Tepper RI, Weller PF, Morgan ES, Estrella P, Monahan-Earley RA, et al. Piecemeal degranulation of mast cells in the inflammatory eyelid lesions of interleukin-4 transgenic mice. Evidence of mast cell histamine release in vivo by diamine oxidase-gold enzyme-affinity ultrastructural cytochemistry. Blood (1994) 83(12):3600-12.
84. Chyczewski L, Debek W, Chyczewska E, Debek K, Bankowski E. Morphology of lung mast cells in rats treated with bleomycin. Exp Toxicol Pathol (1996) 48(6):515-7. doi:10.1016/S0940-2993(96)80070-4
85. Vicario M, Guilarte M, Alonso C, Yang P, Martinez C, Ramos L, et al. Chronological assessment of mast cell-mediated gut dysfunction and mucosal inflammation in a rat model of chronic psychosocial stress. Brain Behav Immun (2010) 24(7):1166-75. doi:10.1016/j.bbi.2010.06.002
86. Yan XJ, Feng CC, Liu Q, Zhang LY, Dong X, Liu ZL, et al. Vagal afferents mediate antinociception of estrogen in a rat model of visceral pain: the involvement of intestinal mucosal mast cells and 5-hydroxytryptamine 3 signaling. J Pain (2014) 15(2):204-17. doi:10.1016/j.jpain.2013.10.012
87. Iwamoto S, Asada Y, Ebihara N, Hori K, Okayama Y, Kashiwakura J, et al. Interaction between conjunctival epithelial cells and mast cells induces CCL2 expression and piecemeal degranulation in mast cells. Invest Ophthalmol Vis Sci (2013) 54(4):2465-73. doi:10.1167/iovs.12-10664
88. McCurdy JD, Olynych TJ, Maher LH, Marshall JS. Cutting edge: distinct Toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells. J Immunol (2003) 170(4):1625-9. doi:10.4049/jimmunol.170.4.1625
89. Frossi B, D'Inca F, Crivellato E, Sibilano R, Gri G, Mongillo M, et al. Single-cell dynamics of mast cell-CD4+ CD25+ regulatory T cell interactions. Eur J Immunol (2011) 41(7):1872-82. doi:10.1002/eji.201041300
90. Crivellato E, Nico B, Gallo VP, Ribatti D. Cell secretion mediated by granule-associated vesicle transport: a glimpse at evolution. Anat Rec (2010) 293(7):1115-24. doi:10.1002/ar.21146
91. Woska JR Jr., Gillespie ME. SNARE complex-mediated degranulation in mast cells. J Cell Mol Med (2012) 16(4):649-56. doi:10.1111/j.1582-4934.2011.01443.x
92. Sander LE, Frank SP, Bolat S, Blank U, Galli T, Bigalke H, et al. Vesicle associated membrane protein (VAMP)-7 and VAMP-8, but not VAMP-2 or VAMP-3, are required for activation-induced degranulation of mature human mast cells. Eur J Immunol (2008) 38(3):855-63. doi:10.1002/eji.200737634
93. Goishi K, Mizuno K, Nakanishi H, Sasaki T. Involvement of Rab27 in antigen-induced histamine release from rat basophilic leukemia 2H3 cells. Biochem Biophys Res Commun (2004) 324(1):294-301. doi:10.1016/j.bbrc.2004.09.050
94. Martin-Verdeaux S, Pombo I, Iannascoli B, Roa M, Varin-Blank N, Rivera J, et al. Evidence of a role for Munc18-2 and microtubules in mast cell granule exocytosis. J Cell Sci (2003) 116(Pt 2):325-34. doi:10.1242/jcs.00216
95. Tadokoro S, Kurimoto T, Nakanishi M, Hirashima N. Munc18-2 regulates exocytotic membrane fusion positively interacting with syntaxin-3 in RBL-2H3 cells. Mol Immunol (2007) 44(13):3427-33. doi:10.1016/j.molimm.2007.02.013
96. Tadokoro S, Nakanishi M, Hirashima N. Complexin II facilitates exocytotic release in mast cells by enhancing Ca2+ sensitivity of the fusion process. J Cell Sci (2005) 118(Pt 10):2239-46. doi:10.1242/jcs.02338
97. Hammel I, Meilijson I. The stealthy nano-machine behind mast cell granule size distribution. Mol Immunol (2015) 63(1):45-54. doi:10.1016/j.molimm.2014.02.005
98. Jena BP. Secretory vesicles transiently dock and fuse at the porosome to discharge contents during cell secretion. Cell Biol Int (2010) 34(1):3-12. doi:10.1042/CBI20090161
99. Baram D, Peng Z, Medalia O, Mekori YA, Sagi-Eisenberg R. Synaptotagmin II negatively regulates MHC class II presentation by mast cells. Mol Immunol (2002) 38(16-18):1347-52. doi:10.1016/S0161-5890(02)00086-X
100. Haberman Y, Ziv I, Gorzalczany Y, Hirschberg K, Mittleman L, Fukuda M, et al. Synaptotagmin (Syt) IX is an essential determinant for protein sorting to secretory granules in mast cells. Blood (2007) 109(8):3385-92. doi:10.1182/blood-2006-07-033126
101. Roa M, Paumet F, Le Mao J, David B, Blank U. Involvement of the ras-like GTPase rab3d in RBL-2H3 mast cell exocytosis following stimulation via high affinity IgE receptors (Fc epsilonRI). J Immunol (1997) 159(6):2815-23.
102. Smith J, Thompson N, Thompson J, Armstrong J, Hayes B, Crofts A, et al. Rat basophilic leukaemia (RBL) cells overexpressing Rab3a have a reversible block in antigen-stimulated exocytosis. Biochem J (1997) 323(Pt 2):321-8.
103. Tuvim MJ, Adachi R, Chocano JF, Moore RH, Lampert RM, Zera E, et al. Rab3D, a small GTPase, is localized on mast cell secretory granules and translocates to the plasma membrane upon exocytosis. Am J Respir Cell Mol Biol (1999) 20(1):79-89. doi:10.1165/ajrcmb.20.1.3279
104. Elstak ED, Neeft M, Nehme NT, Voortman J, Cheung M, Goodarzifard M, et al. The munc13-4-rab27 complex is specifically required for tethering secretory lysosomes at the plasma membrane. Blood (2011) 118(6):1570-8. doi:10.1182/blood-2011-02-339523
105. Singh RK, Mizuno K, Wasmeier C, Wavre-Shapton ST, Recchi C, Catz SD, et al. Distinct and opposing roles for Rab27a/Mlph/MyoVa and Rab27b/Munc13-4 in mast cell secretion. FEBS J (2013) 280(3):892-903. doi:10.1111/febs.12081
106. Mizuno K, Tolmachova T, Ushakov DS, Romao M, Abrink M, Ferenczi MA, et al. Rab27b regulates mast cell granule dynamics and secretion. Traffic (2007) 8(7):883-92. doi:10.1111/j.1600-0854.2007.00571.x
107. Hong-Geller E, Cerione RA. Cdc42 and Rac stimulate exocytosis of secretory granules by activating the IP3/calcium pathway in RBL-2H3 mast cells. J Cell Biol (2000) 148(3):481-94. doi:10.1083/jcb.148.3.481
108. Hong-Geller E, Holowka D, Siraganian RP, Baird B, Cerione RA. Activated Cdc42/Rac reconstitutes Fcepsilon RI-mediated Ca2+ mobilization and degranulation in mutant RBL mast cells. Proc Natl Acad Sci U S A (2001) 98(3):1154-9. doi:10.1073/pnas.98.3.1154
109. Baier A, Ndoh VN, Lacy P, Eitzen G. Rac1 and Rac2 control distinct events during antigen-stimulated mast cell exocytosis. J Leukoc Biol (2014) 95:763-74. doi:10.1189/jlb.0513281
110. Ogawa K, Tanaka Y, Uruno T, Duan X, Harada Y, Sanematsu F, et al. DOCK5 functions as a key signaling adaptor that links FcepsilonRI signals to microtubule dynamics during mast cell degranulation. J Exp Med (2014) 211(7):1407-19. doi:10.1084/jem.20131926
111. Haddock BJ, Zhu Y, Doyle SP, Abdullah LH, Davis CW. Role of MARCKS in regulated secretion from mast cells and airway goblet cells. Am J Physiol Lung Cell Mol Physiol (2014) 306(10):L925-36. doi:10.1152/ajplung.00213.2013
112. Bond LM, Peden AA, Kendrick-Jones J, Sellers JR, Buss F. Myosin VI and its binding partner optineurin are involved in secretory vesicle fusion at the plasma membrane. Mol Biol Cell (2011) 22(1):54-65. doi:10.1091/mbc.E10-06-0553
113. Fahrner M, Derler I, Jardin I, Romanin C. The STIM1/Orai signaling machinery. Channels (2013) 7(5):330-43. doi:10.4161/chan.26742
114. Ashmole I, Bradding P. Ion channels regulating mast cell biology. Clin Exp Allergy (2013) 43(5):491-502. doi:10.1111/cea.12043
115. Inoh Y, Tadokoro S, Tanabe H, Inoue M, Hirashima N, Nakanishi M, et al. Inhibitory effects of a cationic liposome on allergic reaction mediated by mast cell activation. Biochem Pharmacol (2013) 86(12):1731-8. doi:10.1016/j.bcp.2013.09.023
116. Ma HT, Beaven MA. Regulators of Ca(2+) signaling in mast cells: potential targets for treatment of mast cell-related diseases? Adv Exp Med Biol (2011) 716:62-90. doi:10.1007/978-1-4419-9533-9_5
117. Ushio H, Ueno T, Kojima Y, Komatsu M, Tanaka S, Yamamoto A, et al. Crucial role for autophagy in degranulation of mast cells. J Allergy Clin Immunol (2011) 127(5):1267-76e6. doi:10.1016/j.jaci.2010.12.1078
118. Kowal J, Tkach M, Thery C. Biogenesis and secretion of exosomes. Curr Opin Cell Biol (2014) 29C:116-25. doi:10.1016/j.ceb.2014.05.004
119. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol (2007) 9(6):654-9. doi:10.1038/ncb1596
120. Ekstrom K, Valadi H, Sjostrand M, Malmhall C, Bossios A, Eldh M, et al. Characterization of mRNA and microRNA in human mast cell-derived exosomes and their transfer to other mast cells and blood CD34 progenitor cells. J Extracell Vesicles (2012) 1:18389. doi:10.3402/jev.v1i0.18389
121. Skokos D, Botros HG, Demeure C, Morin J, Peronet R, Birkenmeier G, et al. Mast cell-derived exosomes induce phenotypic and functional maturation of dendritic cells and elicit specific immune responses in vivo. J Immunol (2003) 170(6):3037-45. doi:10.4049/jimmunol.170.6.3037
122. Merluzzi S, Betto E, Ceccaroni AA, Magris R, Giunta M, Mion F. Mast cells, basophils and B cell connection network. Mol Immunol (2015) 63(1):94-103. doi:10.1016/j.molimm.2014.02.016
123. Villarroya-Beltri C, Baixauli F, Gutierrez-Vazquez C, Sanchez-Madrid F, Mittelbrunn M. Sorting it out: regulation of exosome loading. Semin Cancer Biol (2014) 28C:3-13. doi:10.1016/j.semcancer.2014.04.009
124. Frank SP, Thon KP, Bischoff SC, Lorentz A. SNAP-23 and syntaxin-3 are required for chemokine release by mature human mast cells. Mol Immunol (2011) 49(1-2):353-8. doi:10.1016/j.molimm.2011.09.011
125. Tiwari N, Wang CC, Brochetta C, Ke G, Vita F, Qi Z, et al. VAMP-8 segregates mast cell-preformed mediator exocytosis from cytokine trafficking pathways. Blood (2008) 111(7):3665-74. doi:10.1182/blood-2007-07-103309
126. Hogaboam CM, Donigi-Gale D, Shoupe TS, Bissonnette EY, Befus AD, Wallace JL. Platelet-activating factor synthesis by peritoneal mast cells and its inhibition by two quinoline-based compounds. Br J Pharmacol (1992) 105(1):87-92. doi:10.1111/j.1476-5381.1992.tb14215.x
127. Mencia-Huerta JM, Lewis RA, Razin E, Austen KF. Antigen-initiated release of platelet-activating factor (PAF-acether) from mouse bone marrow-derived mast cells sensitized with monoclonal IgE. J Immunol (1983) 131(6):2958-64.
128. Schleimer RP, Davidson DA, Lichtenstein LM, Adkinson NF Jr. Selective inhibition of arachidonic acid metabolite release from human lung tissue by antiinflammatory steroids. J Immunol (1986) 136(8):3006-11.
129. Boyce JA. Eicosanoid mediators of mast cells: receptors, regulation of synthesis, and pathobiologic implications. Chem Immunol Allergy (2005) 87:59-79. doi:10.1159/000087571
130. Peters-Golden M, Canetti C, Mancuso P, Coffey MJ. Leukotrienes: underappreciated mediators of innate immune responses. J Immunol (2005) 174(2):589-94. doi:10.4049/jimmunol.174.2.589
131. Joo M, Sadikot RT. PGD synthase and PGD2 in immune response. Mediators Inflamm (2012) 2012:503128. doi:10.1155/2012/503128
132. Moon TC, Campos-Alberto E, Yoshimura T, Bredo G, Rieger AM, Puttagunta L, et al. Expression of DP2 (CRTh2), a prostaglandin D2 receptor, in human mast cells. PLoS One (2014) 9(9):e108595. doi:10.1371/journal.pone.0108595
133. Binda C, Genier S, Cartier A, Larrivee JF, Stankova J, Young JC, et al. A G protein-coupled receptor and the intracellular synthase of its agonist functionally cooperate. J Cell Biol (2014) 204(3):377-93. doi:10.1083/jcb.201304015
134. Brock TG, McNish RW, Peters-Golden M. Capacity for repeatable leukotriene generation after transient stimulation of mast cells and macrophages. Biochem J (1998) 329(Pt 3):519-25.
135. Brock TG, McNish RW, Peters-Golden M. Translocation and leukotriene synthetic capacity of nuclear 5-lipoxygenase in rat basophilic leukemia cells and alveolar macrophages. J Biol Chem (1995) 270(37):21652-8. doi:10.1074/jbc.270.37.21652
136. Balestrieri B, Hsu VW, Gilbert H, Leslie CC, Han WK, Bonventre JV, et al. Group V secretory phospholipase A2 translocates to the phagosome after zymosan stimulation of mouse peritoneal macrophages and regulates phagocytosis. J Biol Chem (2006) 281(10):6691-8. doi:10.1074/jbc.M508314200
137. Dvorak AM, Dvorak HF, Peters SP, Shulman ES, MacGlashan DW Jr., Pyne K, et al. Lipid bodies: cytoplasmic organelles important to arachidonate metabolism in macrophages and mast cells. J Immunol (1983) 131(6):2965-76.
138. Pacheco P, Bozza FA, Gomes RN, Bozza M, Weller PF, Castro-Faria-Neto HC, et al. Lipopolysaccharide-induced leukocyte lipid body formation in vivo: innate immunity elicited intracellular Loci involved in eicosanoid metabolism. J Immunol (2002) 169(11):6498-506. doi:10.4049/jimmunol.169.11.6498
139. Bozza PT, Bakker-Abreu I, Navarro-Xavier RA, Bandeira-Melo C. Lipid body function in eicosanoid synthesis: an update. Prostaglandins Leukot Essent Fatty Acids (2011) 85(5):205-13. doi:10.1016/j.plefa.2011.04.020
140. Thiam AR, Farese RV Jr., Walther TC. The biophysics and cell biology of lipid droplets. Nat Rev Mol Cell Biol (2013) 14(12):775-86. doi:10.1038/nrm3699
141. Bozza PT, Yu W, Cassara J, Weller PF. Pathways for eosinophil lipid body induction: differing signal transduction in cells from normal and hypereosinophilic subjects. J Leukoc Biol (1998) 64(4):563-9.
142. Beil WJ, Weller PF, Peppercorn MA, Galli SJ, Dvorak AM. Ultrastructural immunogold localization of subcellular sites of TNF-alpha in colonic Crohn's disease. J Leukoc Biol (1995) 58(3):284-98.
143. Reginato AJ, Schumacher HR, Allan DA, Rabinowitz JL. Acute monoarthritis associated with lipid liquid crystals. Ann Rheum Dis (1985) 44(8):537-43. doi:10.1136/ard.44.8.537
144. Dichlberger A, Kovanen PT, Schneider WJ. Mast cells: from lipid droplets to lipid mediators. Clin Sci (2013) 125(3):121-30. doi:10.1042/CS20120602
145. Wilfling F, Haas JT, Walther TC, Farese RV Jr. Lipid droplet biogenesis. Curr Opin Cell Biol (2014) 29C:39-45. doi:10.1016/j.ceb.2014.03.008
146. Bozza PT, Bandeira-Melo C. Mechanisms of leukocyte lipid body formation and function in inflammation. Mem Inst Oswaldo Cruz (2005) 100(Suppl 1):113-20. doi:10.1590/S0074-02762005000900020
147. Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature (2014) 510(7503):92-101. doi:10.1038/nature13479
148. Chan BS, Satriano JA, Pucci M, Schuster VL. Mechanism of prostaglandin E2 transport across the plasma membrane of HeLa cells and Xenopus oocytes expressing the prostaglandin transporter "PGT". J Biol Chem (1998) 273(12):6689-97. doi:10.1074/jbc.273.12.6689
149. Jedlitschky G, Keppler D. Transport of leukotriene C4 and structurally related conjugates. Vitam Horm (2002) 64:153-84. doi:10.1016/S0083-6729(02)64005-1
150. Rius M, Hummel-Eisenbeiss J, Keppler D. ATP-dependent transport of leukotrienes B4 and C4 by the multidrug resistance protein ABCC4 (MRP4). J Pharmacol Exp Ther (2008) 324(1):86-94. doi:10.1124/jpet.107.131342
151. Reid G, Wielinga P, Zelcer N, van der Heijden I, Kuil A, de Haas M, et al. The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs. Proc Natl Acad Sci U S A (2003) 100(16):9244-9. doi:10.1073/pnas.1033060100
152. Lin ZP, Zhu YL, Johnson DR, Rice KP, Nottoli T, Hains BC, et al. Disruption of cAMP and prostaglandin E2 transport by multidrug resistance protein 4 deficiency alters cAMP-mediated signaling and nociceptive response. Mol Pharmacol (2008) 73(1):243-51. doi:10.1124/mol.107.039594
153. Adachi H, Suzuki T, Abe M, Asano N, Mizutamari H, Tanemoto M, et al. Molecular characterization of human and rat organic anion transporter OATP-D. Am J Physiol Renal Physiol (2003) 285(6):F1188-97. doi:10.1152/ajprenal.00402.2002
154. Nishio T, Adachi H, Nakagomi R, Tokui T, Sato E, Tanemoto M, et al. Molecular identification of a rat novel organic anion transporter moat1, which transports prostaglandin D2, leukotriene C4, and taurocholate. Biochem Biophys Res Commun (2000) 275(3):831-8. doi:10.1006/bbrc.2000.3377
155. Burd PR, Rogers HW, Gordon JR, Martin CA, Jayaraman S, Wilson SD, et al. Interleukin 3-dependent and -independent mast cells stimulated with IgE and antigen express multiple cytokines. J Exp Med (1989) 170(1):245-57. doi:10.1084/jem.170.1.245
156. Lewis RA, Soter NA, Diamond PT, Austen KF, Oates JA, Roberts LJ II. Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE. J Immunol (1982) 129(4):1627-31.
157. MacDonald AJ, Pick J, Bissonnette EY, Befus AD. Rat mucosal mast cells: the cultured bone marrow-derived mast cell is biochemically and functionally analogous to its counterpart in vivo. Immunology (1998) 93(4):533-9. doi:10.1046/j.1365-2567.1998.00465.x
158. Gilchrist M, McCauley SD, Befus AD. Expression, localization, and regulation of NOS in human mast cell lines: effects on leukotriene production. Blood (2004) 104(2):462-9. doi:10.1182/blood-2003-08-2990
159. Moon TC, Yoshimura T, Parsons T, Befus AD. Microenvironmental regulation of inducible nitric oxide synthase expression and nitric oxide production in mouse bone marrow-derived mast cells. J Leukoc Biol (2012) 91(4):581-90. doi:10.1189/jlb.0811436
160. Swindle EJ, Metcalfe DD, Coleman JW. Rodent and human mast cells produce functionally significant intracellular reactive oxygen species but not nitric oxide. J Biol Chem (2004) 279(47):48751-9. doi:10.1074/jbc.M409738200
161. Wang XS, Sze Wing S, Kwok Ho Y, Lau HY. Functional characterization of human mast cells cultured from adult peripheral blood. Int Immunopharmacol (2006) 6(5):839-47. doi:10.1016/j.intimp.2005.12.004
162. Kulka M, Sheen CH, Tancowny BP, Grammer LC, Schleimer RP. Neuropeptides activate human mast cell degranulation and chemokine production. Immunology (2008) 123(3):398-410. doi:10.1111/j.1365-2567.2007.02705.x
163. Karimi K, Kool M, Nijkamp FP, Redegeld FA. Substance P can stimulate prostaglandin D(2) and leukotriene C(4) generation without granule exocytosis in murine mast cells. Eur J Pharmacol (2004) 489(1-2):49-54. doi:10.1016/j.ejphar.2004.03.003
164. Ogasawara T, Murakami M, Suzuki-Nishimura T, Uchida MK, Kudo I. Mouse bone marrow-derived mast cells undergo exocytosis, prostanoid generation, and cytokine expression in response to G protein-activating polybasic compounds after coculture with fibroblasts in the presence of c-kit ligand. J Immunol (1997) 158(1):393-404.
165. Reynier-Rebuffel AM, Mathiau P, Callebert J, Dimitriadou V, Farjaudon N, Kacem K, et al. Substance P, calcitonin gene-related peptide, and capsaicin release serotonin from cerebrovascular mast cells. Am J Physiol (1994) 267(5 Pt 2):R1421-9.
166. McNeil BD, Pundir P, Han L, Meeker S, Undem BJ, Kulka M, et al. Identification of the receptor for mast cell basic secretagogues and its critical role in pseudo-allergic drug reactions. Nature (2014) (in press).
167. Niyonsaba F, Someya A, Hirata M, Ogawa H, Nagaoka I. Evaluation of the effects of peptide antibiotics human beta-defensins-1/-2 and LL-37 on histamine release and prostaglandin D(2) production from mast cells. Eur J Immunol (2001) 31(4):1066-75. doi:10.1002/1521-4141(200104)31:4<1066::AID-IMMU1066>3.0.CO;2-#
168. Niyonsaba F, Ushio H, Hara M, Yokoi H, Tominaga M, Takamori K, et al. Antimicrobial peptides human beta-defensins and cathelicidin LL-37 induce the secretion of a pruritogenic cytokine IL-31 by human mast cells. J Immunol (2010) 184(7):3526-34. doi:10.4049/jimmunol.0900712
169. Befus AD, Mowat C, Gilchrist M, Hu J, Solomon S, Bateman A. Neutrophil defensins induce histamine secretion from mast cells: mechanisms of action. J Immunol (1999) 163(2):947-53.
170. Subramanian H, Gupta K, Lee D, Bayir AK, Ahn H, Ali H. Beta-defensins activate human mast cells via Mas-related gene X2. J Immunol (2013) 191(1):345-52. doi:10.4049/jimmunol.1300023
171. Pundir P, Catalli A, Leggiadro C, Douglas SE, Kulka M. Pleurocidin, a novel antimicrobial peptide, induces human mast cell activation through the FPRL1 receptor. Mucosal Immunol (2014) 7(1):177-87. doi:10.1038/mi.2013.37
172. Behrendt H, Rosenkranz U, Schmutzler W. Ultrastructure of isolated human mast cells during histamine release induced by ionophore A 23187. Int Arch Allergy Appl Immunol (1978) 56(2):188-92. doi:10.1159/000232022
173. Balletta A, Lorenz D, Rummel A, Gerhard R, Bigalke H, Wegner F. Human mast cell line-1 (HMC-1) cells exhibit a membrane capacitance increase when dialysed with high free-Ca(2+) and GTPgammaS containing intracellular solution. Eur J Pharmacol (2013) 720(1-3):227-36. doi:10.1016/j.ejphar.2013.10.022
174. Hosokawa J, Suzuki K, Nakagomi D, Tamachi T, Takatori H, Suto A, et al. Role of calcium ionophore A23187-induced activation of IkappaB kinase 2 in mast cells. Int Arch Allergy Immunol (2013) 161(Suppl 2):37-43. doi:10.1159/000350357
175. Sheen CH, Schleimer RP, Kulka M. Codeine induces human mast cell chemokine and cytokine production: involvement of G-protein activation. Allergy (2007) 62(5):532-8. doi:10.1111/j.1398-9995.2007.01345.x
176. Shalit M, Rubinow A, Granit L, Bar-Sela S. Codeine-induced mast cell degranulation in human skin: effect of calcium channel blockers. Ann Allergy (1987) 59(6):461-3.
177. Kalesnikoff J, Huber M, Lam V, Damen JE, Zhang J, Siraganian RP, et al. Monomeric IgE stimulates signaling pathways in mast cells that lead to cytokine production and cell survival. Immunity (2001) 14(6):801-11. doi:10.1016/S1074-7613(01)00159-5
178. Pandey V, Mihara S, Fensome-Green A, Bolsover S, Cockcroft S. Monomeric IgE stimulates NFAT translocation into the nucleus, a rise in cytosol Ca2+, degranulation, and membrane ruffling in the cultured rat basophilic leukemia-2H3 mast cell line. J Immunol (2004) 172(7):4048-58. doi:10.4049/jimmunol.172.7.4048
179. Matsuda K, Piliponsky AM, Iikura M, Nakae S, Wang EW, Dutta SM, et al. Monomeric IgE enhances human mast cell chemokine production: IL-4 augments and dexamethasone suppresses the response. J Allergy Clin Immunol (2005) 116(6):1357-63. doi:10.1016/j.jaci.2005.08.042
180. Marshall JS, Gomi K, Blennerhassett MG, Bienenstock J. Nerve growth factor modifies the expression of inflammatory cytokines by mast cells via a prostanoid-dependent mechanism. J Immunol (1999) 162(7):4271-6.
181. Tomioka M, Stead RH, Nielsen L, Coughlin MD, Bienenstock J. Nerve growth factor enhances antigen and other secretagogue-induced histamine release from rat peritoneal mast cells in the absence of phosphatidylserine. J Allergy Clin Immunol (1988) 82(4):599-607. doi:10.1016/0091-6749(88)90971-2
182. Yang Z, Marshall JS. Zymosan treatment of mouse mast cells enhances dectin-1 expression and induces dectin-1-dependent reactive oxygen species (ROS) generation. Immunobiology (2009) 214(4):321-30. doi:10.1016/j.imbio.2008.09.002
183. Sundstrom JB, Hair GA, Ansari AA, Secor WE, Gilfillan AM, Metcalfe DD, et al. IgE-FcepsilonRI interactions determine HIV coreceptor usage and susceptibility to infection during ontogeny of mast cells. J Immunol (2009) 182(10):6401-9. doi:10.4049/jimmunol.0801481
184. Kulka M, Alexopoulou L, Flavell RA, Metcalfe DD. Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3. J Allergy Clin Immunol (2004) 114(1):174-82. doi:10.1016/j.jaci.2004.03.049
185. King CA, Marshall JS, Alshurafa H, Anderson R. Release of vasoactive cytokines by antibody-enhanced dengue virus infection of a human mast cell/basophil line. J Virol (2000) 74(15):7146-50. doi:10.1128/JVI.74.15.7146-7150.2000
186. McCurdy JD, Lin TJ, Marshall JS. Toll-like receptor 4-mediated activation of murine mast cells. J Leukoc Biol (2001) 70(6):977-84. doi:10.1152/physrev.00031.2002
187. Smrz D, Bandara G, Beaven MA, Metcalfe DD, Gilfillan AM. Prevention of F-actin assembly switches the response to SCF from chemotaxis to degranulation in human mast cells. Eur J Immunol (2013) 43(7):1873-82. doi:10.1002/eji.201243214
188. MacNeil AJ, Junkins RD, Wu Z, Lin TJ. Stem cell factor induces AP-1-dependent mast cell IL-6 production via MAPK kinase 3 activity. J Leukoc Biol (2014) 95(6):903-15. doi:10.1189/jlb.0713401
189. Kojima R, Ohno T, Iikura M, Niki T, Hirashima M, Iwaya K, et al. Galectin-9 enhances cytokine secretion, but suppresses survival and degranulation, in human mast cell line. PLoS One (2014) 9(1):e86106. doi:10.1371/journal.pone.0086106
190. Erdei A, Andrasfalvy M, Peterfy H, Toth G, Pecht I. Regulation of mast cell activation by complement-derived peptides. Immunol Lett (2004) 92(1-2):39-42. doi:10.1016/j.imlet.2003.11.019
191. Hartmann K, Henz BM, Kruger-Krasagakes S, Kohl J, Burger R, Guhl S, et al. C3a and C5a stimulate chemotaxis of human mast cells. Blood (1997) 89(8):2863-70.
192. El-Lati SG, Dahinden CA, Church MK. Complement peptides C3a- and C5a-induced mediator release from dissociated human skin mast cells. J Invest Dermatol (1994) 102(5):803-6. doi:10.1111/1523-1747.ep12378589
193. Mendes MA, Palma MS. Two new bradykinin-related peptides from the venom of the social wasp Protopolybia exigua (Saussure). Peptides (2006) 27(11):2632-9. doi:10.1016/j.peptides.2006.05.018
194. Hochman DJ, Collaco CR, Brooks EG. Acrolein induction of oxidative stress and degranulation in mast cells. Environ Toxicol (2014) 29(8):908-15. doi:10.1002/tox.21818
195. Pignatti P, Frossi B, Pala G, Negri S, Oman H, Perfetti L, et al. Oxidative activity of ammonium persulfate salt on mast cells and basophils: implication in hairdressers' asthma. Int Arch Allergy Immunol (2013) 160(4):409-19. doi:10.1159/000343020
196. Sick E, Brehin S, Andre P, Coupin G, Landry Y, Takeda K, et al. Advanced glycation end products (AGEs) activate mast cells. Br J Pharmacol (2010) 161(2):442-55. doi:10.1111/j.1476-5381.2010.00905.x
197. Iddamalgoda A, Le QT, Ito K, Tanaka K, Kojima H, Kido H. Mast cell tryptase and photoaging: possible involvement in the degradation of extra cellular matrix and basement membrane proteins. Arch Dermatol Res (2008) 300(Suppl 1):S69-76. doi:10.1007/s00403-007-0806-1
198. Collaco CR, Hochman DJ, Goldblum RM, Brooks EG. Effect of sodium sulfite on mast cell degranulation and oxidant stress. Ann Allergy Asthma Immunol (2006) 96(4):550-6. doi:10.1016/S1081-1206(10)63549-1
199. Yang W, Lee S, Lee J, Bae Y, Kim D. Silver nanoparticle-induced degranulation observed with quantitative phase microscopy. J Biomed Opt (2010) 15(4):045005. doi:10.1117/1.3470104
200. Wang Y, Chen Z, Ba T, Pu J, Chen T, Song Y, et al. Susceptibility of young and adult rats to the oral toxicity of titanium dioxide nanoparticles. Small (2013) 9(9-10):1742-52. doi:10.1002/smll.201201185
201. Swindle EJ, Coleman JW, DeLeo FR, Metcalfe DD. FcepsilonRI- and Fcgamma receptor-mediated production of reactive oxygen species by mast cells is lipoxygenase- and cyclooxygenase-dependent and NADPH oxidase-independent. J Immunol (2007) 179(10):7059-71. doi:10.4049/jimmunol.179.10.7059
202. Wolfreys K, Oliveira DB. Alterations in intracellular reactive oxygen species generation and redox potential modulate mast cell function. Eur J Immunol (1997) 27(1):297-306. doi:10.1002/eji.1830270143
203. Komiyama H, Miyake K, Asai K, Mizuno K, Shimada T. Cyclical mechanical stretch enhances degranulation and IL-4 secretion in RBL-2H3 mast cells. Cell Biochem Funct (2014) 32(1):70-6. doi:10.1002/cbf.2973
204. Soule BP, Brown JM, Kushnir-Sukhov NM, Simone NL, Mitchell JB, Metcalfe DD. Effects of gamma radiation on FcepsilonRI and TLR-mediated mast cell activation. J Immunol (2007) 179(5):3276-86. doi:10.4049/jimmunol.179.5.3276
205. Cabeza JM, Acosta J, Ales E. Mechanisms of granule membrane recapture following exocytosis in intact mast cells. J Biol Chem (2013) 288(28):20293-305. doi:10.1074/jbc.M113.459065
206. Anlauf M, Schafer MK, Schwark T, von Wurmb-Schwark N, Brand V, Sipos B, et al. Vesicular monoamine transporter 2 (VMAT2) expression in hematopoietic cells and in patients with systemic mastocytosis. J Histochem Cytochem (2006) 54(2):201-13. doi:10.1369/jhc.5A6739.2005
207. Garcia-Faroldi G, Melo FR, Bruemmer D, Conneely OM, Pejler G, Lundequist A. Nuclear receptor 4a3 (nr4a3) regulates murine mast cell responses and granule content. PLoS One (2014) 9(2):2. doi:10.1371/journal.pone.0089311
208. Borges R, Dominguez N, Estevez-Herrera J, Pereda D, Machado JD. Vesicular Ca2+ mediates granule motion and exocytosis. Cell Calcium (2012) 51(3-4):338-41. doi:10.1016/j.ceca.2011.12.009
209. Bonnemaison M, Back N, Lin Y, Bonifacino JS, Mains R, Eipper B. AP-1A controls secretory granule biogenesis and trafficking of membrane secretory granule proteins. Traffic (2014) 15(10):1099-121. doi:10.1111/tra.12194
210. Bultema JJ, Di Pietro SM. Cell type-specific Rab32 and Rab38 cooperate with the ubiquitous lysosome biogenesis machinery to synthesize specialized lysosome-related organelles. Small GTPases (2013) 4(1):16-21. doi:10.4161/sgtp.22349